Services

Pharmaceutical and Diagnostic Resources

PDR is a joint venture between IHMA and Blaine Healthcare Associates, Inc. that provides clients with practical microbiological testing strategies for their products. Makers of oral and injectable antibiotics face intense competitive pressure to make their new compounds available on automated Antimicrobial Susceptibility Testing (AST) systems. PDR has a proven track record in helping pharmaceutical companies work through the development and clinical maze at the AST manufacturers and into FDA's approval process for all major commercial systems.

PDR provides:

  • A viable link between the AST manufacturers and the pharmaceutical company
  • Manufacturers Interface and Performance Program (MIPP™)
  • Design and management of investigational use only (IUO) programs for new antimicrobials
  • Step-by-step guidance for preparing new compounds for testing soon after launch